PMC:7558333 / 21340-22182 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T46","span":{"begin":37,"end":42},"obj":"Body_part"},{"id":"T47","span":{"begin":119,"end":124},"obj":"Body_part"},{"id":"T48","span":{"begin":490,"end":495},"obj":"Body_part"},{"id":"T49","span":{"begin":812,"end":816},"obj":"Body_part"}],"attributes":[{"id":"A46","pred":"fma_id","subj":"T46","obj":"http://purl.org/sig/ont/fma/fma9576"},{"id":"A47","pred":"fma_id","subj":"T47","obj":"http://purl.org/sig/ont/fma/fma9576"},{"id":"A48","pred":"fma_id","subj":"T48","obj":"http://purl.org/sig/ont/fma/fma9576"},{"id":"A49","pred":"fma_id","subj":"T49","obj":"http://purl.org/sig/ont/fma/fma7195"}],"text":"Figure 2 Computed tomography of the chest of patients with COVID-19 with secondary invasive aspergillosis. Unenhanced chest CT in a 59-year-old man with COVID-19 and biological markers of invasive aspergillosis performed at baseline (A) and at 12-day follow-up (B) showing subpleural ground-glass and reticular opacities presumed to correspond to COVID-19 lesions (arrowheads) as well as a right apical consolidation area presumed to correspond to invasive aspergillosis (arrow). Enhanced chest CT in a 69-year-old man with COVID-19 and biological markers of invasive aspergillosis showing at baseline (C) ground-glass opacities (arrowheads), and at 11-day follow-up (D) a left postero-basal consolidation presumed to correspond to invasive aspergillosis (arrow). (346-mm field of view, 512 × 512 image matrix, lung window (W1600/L-500 HU))."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T31","span":{"begin":37,"end":42},"obj":"Body_part"},{"id":"T32","span":{"begin":119,"end":124},"obj":"Body_part"},{"id":"T33","span":{"begin":490,"end":495},"obj":"Body_part"},{"id":"T34","span":{"begin":812,"end":816},"obj":"Body_part"}],"attributes":[{"id":"A31","pred":"uberon_id","subj":"T31","obj":"http://purl.obolibrary.org/obo/UBERON_0001443"},{"id":"A32","pred":"uberon_id","subj":"T32","obj":"http://purl.obolibrary.org/obo/UBERON_0001443"},{"id":"A33","pred":"uberon_id","subj":"T33","obj":"http://purl.obolibrary.org/obo/UBERON_0001443"},{"id":"A34","pred":"uberon_id","subj":"T34","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"}],"text":"Figure 2 Computed tomography of the chest of patients with COVID-19 with secondary invasive aspergillosis. Unenhanced chest CT in a 59-year-old man with COVID-19 and biological markers of invasive aspergillosis performed at baseline (A) and at 12-day follow-up (B) showing subpleural ground-glass and reticular opacities presumed to correspond to COVID-19 lesions (arrowheads) as well as a right apical consolidation area presumed to correspond to invasive aspergillosis (arrow). Enhanced chest CT in a 69-year-old man with COVID-19 and biological markers of invasive aspergillosis showing at baseline (C) ground-glass opacities (arrowheads), and at 11-day follow-up (D) a left postero-basal consolidation presumed to correspond to invasive aspergillosis (arrow). (346-mm field of view, 512 × 512 image matrix, lung window (W1600/L-500 HU))."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T112","span":{"begin":60,"end":68},"obj":"Disease"},{"id":"T113","span":{"begin":84,"end":106},"obj":"Disease"},{"id":"T114","span":{"begin":93,"end":106},"obj":"Disease"},{"id":"T115","span":{"begin":154,"end":162},"obj":"Disease"},{"id":"T116","span":{"begin":189,"end":211},"obj":"Disease"},{"id":"T117","span":{"begin":198,"end":211},"obj":"Disease"},{"id":"T118","span":{"begin":348,"end":356},"obj":"Disease"},{"id":"T119","span":{"begin":449,"end":471},"obj":"Disease"},{"id":"T120","span":{"begin":458,"end":471},"obj":"Disease"},{"id":"T121","span":{"begin":525,"end":533},"obj":"Disease"},{"id":"T122","span":{"begin":560,"end":582},"obj":"Disease"},{"id":"T123","span":{"begin":569,"end":582},"obj":"Disease"},{"id":"T124","span":{"begin":733,"end":755},"obj":"Disease"},{"id":"T125","span":{"begin":742,"end":755},"obj":"Disease"}],"attributes":[{"id":"A112","pred":"mondo_id","subj":"T112","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A113","pred":"mondo_id","subj":"T113","obj":"http://purl.obolibrary.org/obo/MONDO_0000240"},{"id":"A114","pred":"mondo_id","subj":"T114","obj":"http://purl.obolibrary.org/obo/MONDO_0005657"},{"id":"A115","pred":"mondo_id","subj":"T115","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A116","pred":"mondo_id","subj":"T116","obj":"http://purl.obolibrary.org/obo/MONDO_0000240"},{"id":"A117","pred":"mondo_id","subj":"T117","obj":"http://purl.obolibrary.org/obo/MONDO_0005657"},{"id":"A118","pred":"mondo_id","subj":"T118","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A119","pred":"mondo_id","subj":"T119","obj":"http://purl.obolibrary.org/obo/MONDO_0000240"},{"id":"A120","pred":"mondo_id","subj":"T120","obj":"http://purl.obolibrary.org/obo/MONDO_0005657"},{"id":"A121","pred":"mondo_id","subj":"T121","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A122","pred":"mondo_id","subj":"T122","obj":"http://purl.obolibrary.org/obo/MONDO_0000240"},{"id":"A123","pred":"mondo_id","subj":"T123","obj":"http://purl.obolibrary.org/obo/MONDO_0005657"},{"id":"A124","pred":"mondo_id","subj":"T124","obj":"http://purl.obolibrary.org/obo/MONDO_0000240"},{"id":"A125","pred":"mondo_id","subj":"T125","obj":"http://purl.obolibrary.org/obo/MONDO_0005657"}],"text":"Figure 2 Computed tomography of the chest of patients with COVID-19 with secondary invasive aspergillosis. Unenhanced chest CT in a 59-year-old man with COVID-19 and biological markers of invasive aspergillosis performed at baseline (A) and at 12-day follow-up (B) showing subpleural ground-glass and reticular opacities presumed to correspond to COVID-19 lesions (arrowheads) as well as a right apical consolidation area presumed to correspond to invasive aspergillosis (arrow). Enhanced chest CT in a 69-year-old man with COVID-19 and biological markers of invasive aspergillosis showing at baseline (C) ground-glass opacities (arrowheads), and at 11-day follow-up (D) a left postero-basal consolidation presumed to correspond to invasive aspergillosis (arrow). (346-mm field of view, 512 × 512 image matrix, lung window (W1600/L-500 HU))."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T146","span":{"begin":37,"end":42},"obj":"http://www.ebi.ac.uk/efo/EFO_0000965"},{"id":"T147","span":{"begin":119,"end":124},"obj":"http://www.ebi.ac.uk/efo/EFO_0000965"},{"id":"T148","span":{"begin":131,"end":132},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T149","span":{"begin":235,"end":236},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T150","span":{"begin":263,"end":264},"obj":"http://purl.obolibrary.org/obo/CLO_0001021"},{"id":"T151","span":{"begin":389,"end":390},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T152","span":{"begin":490,"end":495},"obj":"http://www.ebi.ac.uk/efo/EFO_0000965"},{"id":"T153","span":{"begin":502,"end":503},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T154","span":{"begin":651,"end":653},"obj":"http://purl.obolibrary.org/obo/CLO_0053733"},{"id":"T155","span":{"begin":668,"end":673},"obj":"http://www.ebi.ac.uk/efo/EFO_0000265"},{"id":"T156","span":{"begin":773,"end":778},"obj":"http://purl.obolibrary.org/obo/UBERON_0007688"},{"id":"T157","span":{"begin":812,"end":816},"obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"T158","span":{"begin":812,"end":816},"obj":"http://www.ebi.ac.uk/efo/EFO_0000934"}],"text":"Figure 2 Computed tomography of the chest of patients with COVID-19 with secondary invasive aspergillosis. Unenhanced chest CT in a 59-year-old man with COVID-19 and biological markers of invasive aspergillosis performed at baseline (A) and at 12-day follow-up (B) showing subpleural ground-glass and reticular opacities presumed to correspond to COVID-19 lesions (arrowheads) as well as a right apical consolidation area presumed to correspond to invasive aspergillosis (arrow). Enhanced chest CT in a 69-year-old man with COVID-19 and biological markers of invasive aspergillosis showing at baseline (C) ground-glass opacities (arrowheads), and at 11-day follow-up (D) a left postero-basal consolidation presumed to correspond to invasive aspergillosis (arrow). (346-mm field of view, 512 × 512 image matrix, lung window (W1600/L-500 HU))."}

{"project":"LitCovid-sentences","denotations":[{"id":"T155","span":{"begin":0,"end":107},"obj":"Sentence"},{"id":"T156","span":{"begin":108,"end":480},"obj":"Sentence"},{"id":"T157","span":{"begin":481,"end":842},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Figure 2 Computed tomography of the chest of patients with COVID-19 with secondary invasive aspergillosis. Unenhanced chest CT in a 59-year-old man with COVID-19 and biological markers of invasive aspergillosis performed at baseline (A) and at 12-day follow-up (B) showing subpleural ground-glass and reticular opacities presumed to correspond to COVID-19 lesions (arrowheads) as well as a right apical consolidation area presumed to correspond to invasive aspergillosis (arrow). Enhanced chest CT in a 69-year-old man with COVID-19 and biological markers of invasive aspergillosis showing at baseline (C) ground-glass opacities (arrowheads), and at 11-day follow-up (D) a left postero-basal consolidation presumed to correspond to invasive aspergillosis (arrow). (346-mm field of view, 512 × 512 image matrix, lung window (W1600/L-500 HU))."}

{"project":"LitCovid-PubTator","denotations":[{"id":"542","span":{"begin":46,"end":54},"obj":"Species"},{"id":"543","span":{"begin":60,"end":68},"obj":"Disease"},{"id":"544","span":{"begin":84,"end":106},"obj":"Disease"},{"id":"545","span":{"begin":154,"end":162},"obj":"Disease"},{"id":"546","span":{"begin":189,"end":211},"obj":"Disease"},{"id":"547","span":{"begin":348,"end":356},"obj":"Disease"},{"id":"548","span":{"begin":449,"end":471},"obj":"Disease"},{"id":"549","span":{"begin":525,"end":533},"obj":"Disease"},{"id":"550","span":{"begin":560,"end":582},"obj":"Disease"},{"id":"551","span":{"begin":733,"end":755},"obj":"Disease"}],"attributes":[{"id":"A542","pred":"tao:has_database_id","subj":"542","obj":"Tax:9606"},{"id":"A543","pred":"tao:has_database_id","subj":"543","obj":"MESH:C000657245"},{"id":"A544","pred":"tao:has_database_id","subj":"544","obj":"MESH:D055744"},{"id":"A545","pred":"tao:has_database_id","subj":"545","obj":"MESH:C000657245"},{"id":"A546","pred":"tao:has_database_id","subj":"546","obj":"MESH:D055744"},{"id":"A547","pred":"tao:has_database_id","subj":"547","obj":"MESH:C000657245"},{"id":"A548","pred":"tao:has_database_id","subj":"548","obj":"MESH:D055744"},{"id":"A549","pred":"tao:has_database_id","subj":"549","obj":"MESH:C000657245"},{"id":"A550","pred":"tao:has_database_id","subj":"550","obj":"MESH:D055744"},{"id":"A551","pred":"tao:has_database_id","subj":"551","obj":"MESH:D055744"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Figure 2 Computed tomography of the chest of patients with COVID-19 with secondary invasive aspergillosis. Unenhanced chest CT in a 59-year-old man with COVID-19 and biological markers of invasive aspergillosis performed at baseline (A) and at 12-day follow-up (B) showing subpleural ground-glass and reticular opacities presumed to correspond to COVID-19 lesions (arrowheads) as well as a right apical consolidation area presumed to correspond to invasive aspergillosis (arrow). Enhanced chest CT in a 69-year-old man with COVID-19 and biological markers of invasive aspergillosis showing at baseline (C) ground-glass opacities (arrowheads), and at 11-day follow-up (D) a left postero-basal consolidation presumed to correspond to invasive aspergillosis (arrow). (346-mm field of view, 512 × 512 image matrix, lung window (W1600/L-500 HU))."}